171 related articles for article (PubMed ID: 17655271)
1. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30.
Revankar CM; Mitchell HD; Field AS; Burai R; Corona C; Ramesh C; Sklar LA; Arterburn JB; Prossnitz ER
ACS Chem Biol; 2007 Aug; 2(8):536-44. PubMed ID: 17655271
[TBL] [Abstract][Full Text] [Related]
2. Virtual and biomolecular screening converge on a selective agonist for GPR30.
Bologa CG; Revankar CM; Young SM; Edwards BS; Arterburn JB; Kiselyov AS; Parker MA; Tkachenko SE; Savchuck NP; Sklar LA; Oprea TI; Prossnitz ER
Nat Chem Biol; 2006 Apr; 2(4):207-12. PubMed ID: 16520733
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol.
Otto C; Rohde-Schulz B; Schwarz G; Fuchs I; Klewer M; Brittain D; Langer G; Bader B; Prelle K; Nubbemeyer R; Fritzemeier KH
Endocrinology; 2008 Oct; 149(10):4846-56. PubMed ID: 18566127
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
5. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane.
Filardo E; Quinn J; Pang Y; Graeber C; Shaw S; Dong J; Thomas P
Endocrinology; 2007 Jul; 148(7):3236-45. PubMed ID: 17379646
[TBL] [Abstract][Full Text] [Related]
6. GPR30: a novel therapeutic target in estrogen-related disease.
Prossnitz ER; Sklar LA; Oprea TI; Arterburn JB
Trends Pharmacol Sci; 2008 Mar; 29(3):116-23. PubMed ID: 18262661
[TBL] [Abstract][Full Text] [Related]
7. The ins and outs of GPR30: a transmembrane estrogen receptor.
Prossnitz ER; Oprea TI; Sklar LA; Arterburn JB
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):350-3. PubMed ID: 18406603
[TBL] [Abstract][Full Text] [Related]
8. A transmembrane intracellular estrogen receptor mediates rapid cell signaling.
Revankar CM; Cimino DF; Sklar LA; Arterburn JB; Prossnitz ER
Science; 2005 Mar; 307(5715):1625-30. PubMed ID: 15705806
[TBL] [Abstract][Full Text] [Related]
9. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.
Lin BC; Suzawa M; Blind RD; Tobias SC; Bulun SE; Scanlan TS; Ingraham HA
Cancer Res; 2009 Jul; 69(13):5415-23. PubMed ID: 19549922
[TBL] [Abstract][Full Text] [Related]
10. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
Thomas P; Pang Y; Filardo EJ; Dong J
Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
[TBL] [Abstract][Full Text] [Related]
11. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release.
Filardo EJ; Thomas P
Trends Endocrinol Metab; 2005 Oct; 16(8):362-7. PubMed ID: 16125968
[TBL] [Abstract][Full Text] [Related]
12. Linkage effects on binding affinity and activation of GPR30 and estrogen receptors ERalpha/beta with tridentate pyridin-2-yl hydrazine tricarbonyl-Re/(99m)Tc(I) chelates.
Ramesh C; Bryant B; Nayak T; Revankar CM; Anderson T; Carlson KE; Katzenellenbogen JA; Sklar LA; Norenberg JP; Prossnitz ER; Arterburn JB
J Am Chem Soc; 2006 Nov; 128(45):14476-7. PubMed ID: 17090028
[TBL] [Abstract][Full Text] [Related]
13. G Protein-Coupled Estrogen Receptor: Rapid Effects on Hippocampal-Dependent Spatial Memory and Synaptic Plasticity.
Kumar A; Foster TC
Front Endocrinol (Lausanne); 2020; 11():385. PubMed ID: 32587576
[TBL] [Abstract][Full Text] [Related]
14. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of a GPR30 antagonist.
Dennis MK; Burai R; Ramesh C; Petrie WK; Alcon SN; Nayak TK; Bologa CG; Leitao A; Brailoiu E; Deliu E; Dun NJ; Sklar LA; Hathaway HJ; Arterburn JB; Oprea TI; Prossnitz ER
Nat Chem Biol; 2009 Jun; 5(6):421-7. PubMed ID: 19430488
[TBL] [Abstract][Full Text] [Related]
16. GPR30: A G protein-coupled receptor for estrogen.
Prossnitz ER; Arterburn JB; Sklar LA
Mol Cell Endocrinol; 2007 Feb; 265-266():138-42. PubMed ID: 17222505
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane.
Funakoshi T; Yanai A; Shinoda K; Kawano MM; Mizukami Y
Biochem Biophys Res Commun; 2006 Aug; 346(3):904-10. PubMed ID: 16780796
[TBL] [Abstract][Full Text] [Related]
18. The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells.
Yu X; Filardo EJ; Shaikh ZA
Toxicol Appl Pharmacol; 2010 May; 245(1):83-90. PubMed ID: 20153348
[TBL] [Abstract][Full Text] [Related]
19. A critical review of fundamental controversies in the field of GPR30 research.
Langer G; Bader B; Meoli L; Isensee J; Delbeck M; Noppinger PR; Otto C
Steroids; 2010; 75(8-9):603-10. PubMed ID: 20034504
[TBL] [Abstract][Full Text] [Related]
20. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
